Androgenetic Alopecia and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis

June 2013 in “ Journal of The American Academy of Dermatology ”

Aline Amoretti, Humberto Laydner, Wilma F. Bergfeld

androgenetic alopecia vertex pattern androgenetic alopecia AGA male pattern baldness

TLDR Vertex pattern hair loss linked to higher prostate cancer risk.

This systematic review and meta-analysis found that vertex pattern androgenetic alopecia (AGA) was associated with an increased risk of prostate cancer, while other patterns of AGA did not show a significant association with prostate cancer. The study suggests that further studies are needed to better understand the potential association between vertex pattern AGA and prostate cancer.

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

Differential Expression Analysis of Balding and Nonbalding Dermal Papilla MicroRNAs in Male Pattern Baldness Using a MicroRNA Amplification Profiling Method

research Differential Expression Analysis of Balding and Nonbalding Dermal Papilla MicroRNAs in Male Pattern Baldness Using a MicroRNA Amplification Profiling Method

29 citations, October 2011 in “British Journal of Dermatology”

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

research Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

28 citations, August 2011 in “Journal of The American Academy of Dermatology”

Early hair loss may indicate prostate issues.

research Male Pattern Baldness and the Risk of Prostate Cancer

38 citations, February 2011 in “Annals of Oncology”

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

research Molecular Basis of Androgenetic Alopecia: From Androgen to Paracrine Mediators Through Dermal Papilla

122 citations, November 2010 in “Journal of Dermatological Science”

Male pattern baldness involves hormones and cell signals affecting hair growth.

research Androgenic Alopecia Is Not Useful as an Indicator of Men at High Risk of Prostate Cancer

28 citations, June 2010 in “European Journal of Cancer”

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

research Male Pattern Baldness and Prostate Cancer Risk in a Population-Based Case-Control Study

29 citations, March 2010 in “Cancer epidemiology”

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

research Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels

30 citations, January 2008 in “The Aging Male”

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Related Community Posts Join

6 / 1000+ results

community Evidenced Based Meta-Analyses and Systemic Reviews of Androgenic Alopecia and Treatments

in Research/Science 15 upvotes 4 years ago

Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Hair Loss Drugs Ranked in Order of Efficacy

in Research/Science 67 upvotes 11 months ago

Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

community AGA evaluation and first steps - BEGINNER MEGAPOST

in Chat 73 upvotes 2 months ago

The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 1 month ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.